H.C. Wainwright Maintains TScan Therapeutics(TCRX.US) With Buy Rating, Maintains Target Price $15

Futu NewsNov 15 20:33 · Ratings

TScan Therapeutics Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow JonesNov 15 19:44 · Ratings

BTIG Maintains TScan Therapeutics(TCRX.US) With Buy Rating, Maintains Target Price $12

Futu NewsNov 14 02:32 · Ratings

A Quick Look at Today's Ratings for TScan Therapeutics(TCRX.US), With a Forecast Between $11 to $14

Futu NewsNov 13 21:00 · Ratings

Analysts Offer Insights on Healthcare Companies: TScan Therapeutics (TCRX), Legend Biotech (LEGN) and ICU Medical (ICUI)

TipRanksNov 13 18:11 · Ratings

Needham Reiterates Buy on TScan Therapeutics, Maintains $11 Price Target

BenzingaNov 13 01:28 · Ratings